1. Home
  2. SUPN vs ALG Comparison

SUPN vs ALG Comparison

Compare SUPN & ALG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • ALG
  • Stock Information
  • Founded
  • SUPN 2005
  • ALG 1955
  • Country
  • SUPN United States
  • ALG United States
  • Employees
  • SUPN N/A
  • ALG N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • ALG Industrial Machinery/Components
  • Sector
  • SUPN Health Care
  • ALG Industrials
  • Exchange
  • SUPN Nasdaq
  • ALG Nasdaq
  • Market Cap
  • SUPN 2.1B
  • ALG 2.2B
  • IPO Year
  • SUPN 2012
  • ALG 1993
  • Fundamental
  • Price
  • SUPN $37.74
  • ALG $182.13
  • Analyst Decision
  • SUPN Hold
  • ALG Strong Buy
  • Analyst Count
  • SUPN 1
  • ALG 3
  • Target Price
  • SUPN $36.00
  • ALG $231.33
  • AVG Volume (30 Days)
  • SUPN 376.5K
  • ALG 136.3K
  • Earning Date
  • SUPN 02-25-2025
  • ALG 02-20-2025
  • Dividend Yield
  • SUPN N/A
  • ALG 0.66%
  • EPS Growth
  • SUPN 130.79
  • ALG N/A
  • EPS
  • SUPN 1.07
  • ALG 9.93
  • Revenue
  • SUPN $651,972,000.00
  • ALG $1,660,732,000.00
  • Revenue This Year
  • SUPN $7.82
  • ALG N/A
  • Revenue Next Year
  • SUPN N/A
  • ALG $0.72
  • P/E Ratio
  • SUPN $35.28
  • ALG $18.36
  • Revenue Growth
  • SUPN 6.79
  • ALG 0.12
  • 52 Week Low
  • SUPN $25.53
  • ALG $163.74
  • 52 Week High
  • SUPN $39.37
  • ALG $231.40
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 57.78
  • ALG 45.91
  • Support Level
  • SUPN $36.48
  • ALG $179.86
  • Resistance Level
  • SUPN $38.68
  • ALG $182.45
  • Average True Range (ATR)
  • SUPN 1.06
  • ALG 3.90
  • MACD
  • SUPN 0.09
  • ALG 0.24
  • Stochastic Oscillator
  • SUPN 68.46
  • ALG 61.86

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design and manufacturing of agricultural equipment and infrastructure maintenance equipment. Its products include tractor-mounted mowing and other vegetation maintenance equipment, street sweepers, excavators, vacuum trucks, snow removal equipment, leaf collection equipment, pothole patchers, zero-turn radius mowers, agricultural implements, and related aftermarket parts. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of its revenue from Vegetation Management. Geographically, the company generates majority of the revenue from the United States.

Share on Social Networks: